In this issue:
A comparison of CT colonography and faecal immunochemical testing for CRC
Clinicopathologic and survival differences between DO and GOJ
The AIO INTEGA RCT
Nivolumab, gemcitabine + cisplatin or nivolumab + ipilimumab in BTC
Very-hot food and beverage exposure and OESCC
FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic CRC
Tea consumption and gastric cancer
FOLFIRINOX vs gemcitabine/ nabpaclitaxel for advanced pancreatic cancer chemotherapy on survival in advanced pancreatic cancer
Anti-PD-1 as a treatment in dMMR/MSI-H rectal cancer
The survival benefit of AC following NAT
Please login below to download this issue (PDF)